Leveraging the Pre-Approval Information Safe Harbor to Accelerate Patient Access
/amcp.png?h=225&iar=0&w=225&hash=27293E62D08FE9BD7655F4EBCCA08F5B)
Watch the webinar for an engaging & informative discussion that dives into the evolving landscape of pre-approval information exchange (PIE). AMCP hosted a diverse panel of biopharma and market access experts to guide you through valuable insights and strategies for engaging healthcare decision makers with pre-approval information. Explore these opportunities and innovative solutions for leveraging PIE when collaborating with stakeholders.
Cencora thought leaders shared expertise on how to navigate complex terrain and discover new opportunities for success with up-to-date insights on industry trends.
What you'll learn in this session:
- How PIE has been leveraged by biopharma companies to communicate with healthcare decision makers through various channels.
- The impact of effective PIE strategies on stakeholder engagement and decision making.
- Potential solutions for challenging areas in PIE such as FDA expedited approval pathways and availability of economic/pricing data.
- How digital solutions can be leveraged for PIE and its implications for communication with stakeholders.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.